Literature DB >> 12092660

The incidence of rectal bleeding following three-dimensional conformal radiotherapy of prostatic cancer.

C Kurtman1.   

Abstract

This study evaluated the incidence of rectal bleeding in patients with prostatic carcinoma treated with three-dimensional conformal radiotherapy (3D-CRT). A total of 32 patients received mean 68.87 Gy 3D-CRT, the mean follow up time was 23.68 months. There was not statistically significant difference between the groups of > or = 70 Gy and < 70 Gy in terms of rectal bleeding (p > 0.05). but there was statistically significant difference between the groups of who have previous history and finding of rectal bleeding and who have not previous history and finding of rectal bleeding (p < 0.013). Rectal bleeding of the patients had significant resolution of their symptoms with conservative therapies.

Entities:  

Mesh:

Year:  2001        PMID: 12092660     DOI: 10.1023/a:1015222014865

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  28 in total

1.  The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy.

Authors:  M J Zelefsky; L Happersett; S A Leibel; C M Burman; L Schwartz; A P Dicker; G J Kutcher; Z Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-01       Impact factor: 7.038

2.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

3.  Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma.

Authors:  M J Zelefsky; D Cowen; Z Fuks; M Shike; C Burman; A Jackson; E S Venkatramen; S A Leibel
Journal:  Cancer       Date:  1999-06-01       Impact factor: 6.860

4.  Modeling of normal tissue response to radiation: the critical volume model.

Authors:  A Niemierko; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-01       Impact factor: 7.038

5.  Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.

Authors:  B S Teh; W Y Mai; B M Uhl; M E Augspurger; W H Grant; H H Lu; S Y Woo; L S Carpenter; J K Chiu; E B Butler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-01       Impact factor: 7.038

6.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

Authors:  A Jackson; M W Skwarchuk; M J Zelefsky; D M Cowen; E S Venkatraman; S Levegrun; C M Burman; G J Kutcher; Z Fuks; S A Liebel; C C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-01       Impact factor: 7.038

7.  Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.

Authors:  W G Smit; P A Helle; W L van Putten; A J Wijnmaalen; J J Seldenrath; B H van der Werf-Messing
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-01       Impact factor: 7.038

8.  Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.

Authors:  C Burman; C S Chui; G Kutcher; S Leibel; M Zelefsky; T LoSasso; S Spirou; Q Wu; J Yang; J Stein; R Mohan; Z Fuks; C C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-11-01       Impact factor: 7.038

9.  Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study.

Authors:  M J Zelefsky; Z Fuks; T Wolfe; G J Kutcher; C Burman; C C Ling; E S Venkatraman; S A Leibel
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

10.  Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate.

Authors:  G E Hanks; S A Leibel; J M Krall; S Kramer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.